132 related articles for article (PubMed ID: 4332)
1. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Cox B; Kastin AJ; Schnieden H
Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
[TBL] [Abstract][Full Text] [Related]
2. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
3. The role of dopamine and noradrenaline in temperature control of normal and reserpine-pretreated mice.
Cox B; Tha SJ
J Pharm Pharmacol; 1975 Apr; 27(4):242-7. PubMed ID: 239116
[TBL] [Abstract][Full Text] [Related]
4. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
5. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
Yehuda S; Carasso RL
Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
[TBL] [Abstract][Full Text] [Related]
6. [Compounds stimulating central catecholamine receptors].
Grabowska M
Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
[No Abstract] [Full Text] [Related]
7. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
Kostrzewa RM; White TG; Zadina JE; Kastin AJ
Eur J Pharmacol; 1989 Apr; 163(1):33-42. PubMed ID: 2568266
[TBL] [Abstract][Full Text] [Related]
8. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
Pugsley TA; Lippmann W
Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
[TBL] [Abstract][Full Text] [Related]
9. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats.
Hara C; Kastin AJ
Pharmacol Biochem Behav; 1986 Oct; 25(4):757-61. PubMed ID: 2878442
[TBL] [Abstract][Full Text] [Related]
10. Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Kulkarni SK; Dandiya PC
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):45-50. PubMed ID: 1233511
[TBL] [Abstract][Full Text] [Related]
11. Amantadine and apomorphine: interactions on striatal dopamine receptors.
Cox B
Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
[No Abstract] [Full Text] [Related]
12. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
Kostrzewa RM; Kastin AJ; Spirtes MA
Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
[TBL] [Abstract][Full Text] [Related]
13. Central action of melanostatin (MIF-1) in mice.
Brus R; Szkilnik R; Stanosek B; Makowska B; Piguła J
Acta Physiol Pol; 1984; 35(5-6):447-53. PubMed ID: 6152791
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine does not alter amphetamine-induced dopamine release measured in striatal dialysates.
Kuczenski R; Segal DS; Manley LD
J Neurochem; 1990 May; 54(5):1492-9. PubMed ID: 2324735
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
Gumulka SW; Dinnendahl V; Peters HD; Schönhöfer PS
Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):75-80. PubMed ID: 181689
[TBL] [Abstract][Full Text] [Related]
16. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.
Yehuda S; Kastin AJ
Peptides; 1980; 1(3):243-8. PubMed ID: 6112734
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.
Kostrzewa RM; Kastin AJ; Sobrian SK
Pharmacol Biochem Behav; 1978 Sep; 9(3):375-8. PubMed ID: 30981
[TBL] [Abstract][Full Text] [Related]
18. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
Klusha B; Georgiev V; Petkov V; Markovska V
Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814
[TBL] [Abstract][Full Text] [Related]
19. Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.
Huidobro-Toro JP; Scotti de Carolis A; Longo VG
Pharmacol Biochem Behav; 1975; 3(2):235-42. PubMed ID: 238221
[TBL] [Abstract][Full Text] [Related]
20. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Vaatstra WJ; Eigeman L
Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
